Author: Digirad

Digirad CEO Matt Molchan was recently featured in an interview with MedAxiom. You can read the article on MexAxiom here or read the interview below.

Digirad Imaging Solutions (DIS) will be exhibiting at the 18th annual Scientific Session of the American Society of Nuclear Cardiology Conference. The conference will be held

Digirad Announces Sale of Surgical Imaging Technology Assets to Novadaq Technologies. Agreement Calls for $2 Million of Up Front Consideration, Deferred Contingent Payments, Royalties Digirad

With Digirad stock up 20% this year, “The Street” in New York recently requested an interview with CEO Matt Molchan to discuss Digirad and its

DIS is happy to announce that we are now offering a comprehensive Neuropathy Testing Program. As with the nuclear and ultrasound programs, the service is